High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

Clinical trial NCT00474006 · COMPLETED

Trial details

NCT number: NCT00474006
Sponsor: Cooperative Study Group A for Hematology
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ACUTE MYELOGENOUS LEUKEMIA

Start date: 2001-08-01
Primary completion: 2008-08-01
Enrollment: 398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.